marketing
publication date
CEO
HL Shorts: Why Providers Need to Educate Patients on Medicare Advantage
Combating deceptive marketing by Medicare Advantage plans can benefit patients and providers, says one hospital CEO.
CMO
CMOs: Here's the Deal with Social Media
Health systems and hospitals should have social media policies but should avoid limiting protected speech, a legal expert says.
Revenue Cycle
Podcast: New lessons in the fight for charity care
Federal law requires that all nonprofit hospitals have financial assistance policies to reduce or expunge people's medical bills.
Innovation
Lights, Camera, Healthcare!
Northwell Health looks for brand recognition -- and a platform to talk about the issues -- with Northwell Studios.
HLM Mastermind
Your Health System Needs You on Social Media: 6 Ways to Build a Presence
Workforce, patient engagement, patient trust: Can all of these pain points be solved with social media?
Innovation
Why Patient Experience is Crucial to Healthcare Innovation
Health systems are investing heavily in the patient experience. At Springfield Clinic, that strategy is critical to continued sustainability in...
Pharma
U.S. $772.5B Pharmacy Spend in 2023 Driven by Weight-Loss Drugs
Prescription drug spending grew by 13.5% in 2023, but drug cost inflation was lower than the CPI.
Payer
Lawsuit Alleges Obamacare Plan-Switching Scheme Targeted Low-Income Consumers
Some consumers were switched multiple times or had duplicative policies.
Payer
MA Cuts Will Hurt These Smaller Groups, Not Big Payers
The new rate cut will have a strong impact, but not on big payers.
Payer
Rising Complaints of Unauthorized Obamacare Plan-Switching and Sign-Ups Trigger Concern
CMS says it is 'acutely aware' of the problem and is working on solutions.
Pharma
Biden Is Right. The U.S. Generally Pays Double That of Other Countries for Rx Drugs.
If you went 'anywhere in the world,' you could get a prescription filled for 40% to 60% less than it...
Pharma
Bernie Presses Big Pharma CEOs to Justify 'Outrageously High' U.S. Drug Prices
Senate HELP Committee mulls subpoenas if J&J, Merck CEOs refuse 'invitation' to testify.